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CD14 and the toll-like receptor 4 have been known
to play an important role in lipopolysaccharide-
induced cellular responses in bacterial infections.
Although CD14 and toll-like receptor 4 expression
has been demonstrated in a number of myeloid cells,
much less is known about the expression and func-
tion of these lipopolysaccharide receptors on nonleu-
kocytes. In this study, we demonstrate that human
keratinocytes are capable of expressing functional
CD14 and toll-like receptor 4. Keratinocytes were
found to constitutively express CD14 and toll-like
receptor 4 mRNA that was augmented by exposure
to lipopolysaccharide. Cell surface expression of ker-
atinocyte CD14 and toll-like receptor 4 was detected
by ¯ow cytometry. Lipopolysaccharide binding to
keratinocyte CD14 and toll-like receptor 4 resulted
in a rapid intracellular Ca2+ response, nuclear factor-
kB nuclear translocation, and the secretion of proin-
¯ammatory cytokines and chemokines. These results
have important implications for our understanding
of cutaneous innate immunity to bacterial infections
of the skin. Key words: CD14/cutaneous infection/human
keratinocytes/innate immunity/lipopolysaccharide/toll-like
receptor 4. J Invest Dermatol 119:424±432, 2002
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ipopolysaccharide (LPS), a major component of gram-
negative bacterial cell wall, is a principal initiator of host
antimicrobial innate immune responses (Cryz et al, 1984;
Pugin et al, 1993; Sobottka Ventura et al, 1997). LPS
initiates in¯ammatory responses by inducing the activa-
tion a different subsets of leukocytes and the release of bioactive
proin¯ammatory cytokines such as tumor necrosis factor a (TNF-
a), interleukin-1 (IL-1), IL-6, and IL-8 (Nathan, 1987;
Tannenbaum et al, 1988; Tannenbaum and Hamilton, 1989). In
gram-negative bacterial infections, bacterial derived LPS complexes
with the serum derived LPS-binding protein. LPS-binding protein
acts as a lipid transfer protein that facilitates the binding of LPS
monomers to cellular CD14 (Schumann et al, 1990; Wright et al,
1990). After LPS binding to leukocyte CD14, there is observed a
rapid increase in intracellular Ca2+, cellular tyrosine kinase
phosphorylation, nuclear factor kB (NF-kB) activation, and
cytokine and chemokine production (Pugin et al, 1998). As
CD14 is a glycosylphosphatidylinositol anchored membrane
glycoprotein that lacks an intracellular signaling element, the LPS
receptor complex was assumed to contain an additional signaling
component.
Recently it was reported that a toll-like receptor (TLR) protein
may be the signaling component of the CD14 LPS- binding
receptor complex. TLRs are transmembrane proteins with an
extracellular domain consisting of leucine-rich repeats and
cytoplasmic domain homologs similar to the IL-1 receptor (Rock
et al, 1998). Genetic studies and gene-transfer experiments indicate
that the principal signaling component of the LPS receptor
complex is a TLR family member termed TLR4 (Akashi et al,
2000b; Beutler, 2000a; Wang et al, 2000; Abreu et al, 2001).
Recently, it has been reported that a secreted protein MD-2 also
facilitates CD14±TLR4 cell membrane interactions (Shimazu et al,
1999; Akashi et al, 2000b; Yang et al, 2000; Viriyakosol et al, 2001).
Another TLR, TLR2, has also recently been reported to mediate
cellular responses to microbial components such as gram-positive
bacterial derived peptidoglycan and lipoproteins/lipopeptides
(Schwandner et al, 1999; Yoshimura et al, 1999). We are just
beginning to understand how these TLR cellular pattern recog-
nition receptor proteins recognize microbial derived products to
confer responsiveness to a wide variety of pathogens.
Although there has been signi®cant progress in our understand-
ing of the expression and function of LPS binding and responses in
leukocytes, little is currently known regarding LPS responses in
nonleukocytes such as keratinocytes, which are the ®rst line of
defense against cutaneous microbial invasion. We have recently
reported that human corneal cells express the functionally active
LPS receptor proteins CD14 and TLR4 (Song et al, 2001). To date,
little is known about the molecular mechanism by which LPS
mediates local innate in¯ammatory responses in epithelial tissues.
In this study, we demonstrate for the ®rst time that human
keratinocytes express functional CD14 and TLR4 LPS receptor
complex proteins. This ®nding has important implications for our
understanding of the innate immunologic responses to cutaneous
microbial infections.
MATERIALS AND METHODS
Reagents and cell lines LPS derived from Escherichia coli 026:B6
(Sigma, St. Louis, MO) was used at a concentration of 100 ng per ml
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based on our dose±response studies and other published studies in several
different cell types (Gessani et al, 1993; Flaherty et al, 1997; Wurfel et al,
1997). Fresh normal human keratinocytes were isolated and cultured
from human foreskins as previously described (Boyce and Ham, 1983,
1985). Keratinocytes were cultured in monolayers using serum-free
keratinocyte growth medium (Clonetics, San Diego, CA) at 37°C in a
humidi®ed atmosphere containing 5% CO2. Cell culture medium was
changed every 2±3 d and cells were harvested after passage 3±4. The
human corneal epithelial cell line 10.014 pRSV-T (HCE-T), which we
have previously reported to express CD14 and TLR4 (Song et al, 2001),
was kindly provided by Sherry Ward (Gillette Medical Evaluation
Laboratories, Gaithersburg, MD) (Ward et al, 1995). HCE-T cells were
grown in monolayers using serum-free medium (Clonetics) at 37°C in a
humidi®ed atmosphere containing 5% CO2. Human monocytic leukemia
THP-1 cells and human B lymphoblastoid JY-1 cells (generously
provided by Jack Strominger, Dana Farber Cancer Institute, Boston,
MA) were cultured in RPMI 1640 medium (Gibco BRL, Life
Technologies, Grand Island, NY) and supplemented with 10% fetal
bovine serum (FBS; Hyclone, Logan, UT), 100 U per ml penicillin,
0.25 mg per ml amphotericin B, and 10 mg per ml streptomycin (all
from Gibco-Life Technologies).
Determination of CD14 and TLR4 mRNA expression in cultured
human keratinocytes by northern blot analysis Human
keratinocytes were cultured at a density of 1 3 106 cells per ml, and
mRNA was obtained with an mRNA isolation kit (Roche Molecular
Biochemicals, Indianapolis, IN). Northern blot analysis was performed as
previously described (Quinlan et al, 1998). The CD14 probe used for the
northern blot analysis studies was a 777 bp of CD14-speci®c cDNA
fragment (Song et al, 2001). The TLR4 probe used for the northern blot
studies was a synthesized oligonucleotide (5¢-ACAGAGACTTTATT-
CCCGGTGTGGCCATTG-3¢) based on published TLR4 cDNA
sequences (Rock et al, 1998).
Determination of CD14 and TLR4 mRNA expression in cultured
human keratinocytes by quantitative reverse transcription
polymerase chain reaction (RT-PCR) CD14 and TLR4 mRNA
expression was measured in cultured human keratinocytes 0±24 h after
exposure to LPS by quantitative RT-PCR. Human keratinocytes were
cultured as described earlier, and mRNA was isolated using an mRNA
isolation kit (Roche Molecular Biochemicals). Quantitative RT-PCR
was performed as described in the manufacturer's protocol (SYBR Green
PCR Core Reagents; PE Applied Biosystems, Foster City, CA).
Oligonucleotide primers used to amplify human CD14 and TLR4
cDNA were designed by the manufacturer's software (Primer Express
1.0; PE Applied Biosystems) based on the published sequences (Ferrero
and Goyert, 1988; Rock et al, 1998). The CD14 primer sequences used
were 5¢-CGCTCCGAGATGCATGTG-3¢ for the sense primer and 5¢-
AACGACAGATTGAGGGAGTTCAG-3¢ for the antisense primer. The
TLR4 primer sequences used were 5¢-GCTTACTTTCACTTCCAA-
CAA-3¢ for the sense primer and 5¢-CAATCACCTTTCGGCTT-
TTAT-3¢ for the antisense primer.
Determination of surface CD14 and TLR4 expression on human
keratinocytes by ¯ow cytometry Keratinocyte surface CD14 and
TLR4 were examined by ¯ow cytometry (FACScan, Becton Dickinson,
Raleigh, NC), as previously described (Quinlan et al, 1998). Cells were
incubated with the mouse antihuman CD14 monoclonal antibody
V1153 (Biomeda, Foster City, CA), the mouse antihuman TLR4
monoclonal antibody HTA125 (Bioscience, San Diego, CA), or isotype
control mouse antihuman IgG (H + L; Jackson Immunoresearch, West
Grove, PA) at a ®nal concentration of 10 mg per ml for 1 h on ice. Cells
were then washed twice and incubated with ¯uorescein isothiocyanate
(FITC) conjugated af®nity-puri®ed goat F(ab¢)2 antimouse IgG (H + L;
Jackson Immunoresearch) at a ®nal concentration of 10 mg per ml for
1 h on ice. Cells were then again washed twice and analyzed with a ¯ow
cytometer equipped with the manufacturer's software (CellQuest; Becton
Dickinson) for data acquisition and analysis. For these studies, LPS-
treated JY-1 cells and phorbol 12-myristate 13-acetate (PMA)
Figure 1. Human keratinocytes express CD14 and TLR4 mRNA.
Human keratinocytes were cultured at a density of 1 3 106 cells per ml
and total RNA was obtained from the cells 3 h after the addition of
100 ng per ml LPS. Northern blot analysis was performed using a[32P]-
labeled CD14-speci®c cDNA probe (a) and TLR4-speci®c synthetic
oligonucleotide (b). The relative intensity of each mRNA expression was
normalized with b-actin mRNA expression. The effect of LPS (0±
100 ng per ml) on CD14 and TLR4 mRNA expression was measured
by quantitative RT-PCR in human keratinocytes (c, d). The relative
intensity of each mRNA expression was normalized with the mRNA
expression of 18S rRNA for each experimental condition. The data
shown are representative of triplicate experiments. All values are
expressed as mean 6 SD. Statistically signi®cant differences in CD14 and
TLR4 mRNA expression were determined by ANOVA with
probabilities shown for both the overall signi®cance and the pairwise
comparison (*p < 0.001).
Figure 2. Increased keratinocyte CD14 and TLR4 expression in
response to LPS. CD14 and TLR4 mRNA expression in human
keratinocytes was examined 0, 3, 6, 12, or 24 h after the addition of
100 ng per ml LPS by quantitative RT-PCR (a, b). CD14 and TLR4
mRNA expression was normalized with 18S rRNA mRNA for each
experimental condition. The data shown are representative of triplicate
experiments. All values are expressed as mean 6 SD. Statistically
signi®cant differences in CD14 and TLR4 mRNA expression were
determined by ANOVA (*p < 0.02).
VOL. 119, NO. 2 AUGUST 2002 EXPRESSION OF FUNCTIONAL CD14 AND TLR4 IN HUMAN KERATINOCYTES 425
differentiated THP-1 cells were used as negative and positive control
cultures, respectively (Song et al, 2001).
Immunostaining of CD14 and TLR4 in cultured human
keratinocytes Immunostaining of CD14 and TLR4 in cultured
human keratinocytes was performed as previously described (Lore et al,
1998). Human keratinocytes were seeded at a concentration of 104±105
cells per well into chamber slides (154526, Nalgen Nunc International,
Naperville, IL) and allowed to grow to about 70% con¯uence. Cells
were ®xed in phosphate-buffered saline (PBS) containing 3.7%
paraformaldehyde and permeabilized by incubation with PBS containing
0.2% Triton X100 and 10% FBS for 20 min at room temperature. The
cells were then incubated overnight at 4°C with anti-CD14 monoclonal
antibody (V1153; Biomeda), or anti-TLR4 monoclonal antibody
(HTA125; Bioscience). Cells then were incubated for 1 h at room
temperature with biotin-conjugated antimouse IgG. In control studies,
keratinocytes were incubated with an isotype-matched antibody using
identical experimental conditions as described above. After three washes
in PBS buffer, the samples were incubated with streptavidin±horseradish
peroxidase avidin±biotin complex (StreptABComplex/HRP; Dako,
Carpinteria, CA) for 15±30 min at room temperature. Slides were then
incubated with substrate 3,3¢-diaminobenzidine tablets (Sigma) for 5 min.
The cells were counterstained with hematoxylin for 1±4 min. The
immunostaining of CD14 or TLR4 was observed and photographed by
light microscopy (Olympus Optical, Tokyo, Japan).
Intracellular calcium mobilization studies Intracellular calcium
mobilization was determined to assess the functional response of
keratinocyte CD14 and TLR4 to LPS. Cultured human keratinocytes
were grown on glass coverslips to approximately 50%±70% con¯uence.
Cells were then washed twice with Dulbecco's PBS without Ca2+ and
Mg2+ (Mediatech, Herndon, VA) and incubated for 45 min at 37°C in
PBS containing 2 mM of the ¯uorescent calcium probe fura-2/
acetylmethyl (AM) ester (Molecular Probes, Eugene, OR). After three
washes with this same washing buffer, cells were either treated with
100 ng per ml LPS or pretreated for 20 min with 1 mg per ml anti-
CD14 monoclonal antibody (MY4; Coulter, Miami, FL), anti-TLR4
monoclonal antibody (HTA125; Bioscience) or an antibody directed
against a monomorphic determinant of human class I HLA molecules
(HLA-A, HLA-B, HLA-C; Beckman Coulter, Brea, CA) prior to LPS
addition. Fluorescence was measured with spectro¯uorometer (model
LS50; Perkin Elmer, Branchburg, NJ) with excitation wavelengths of
340 and 380 nm, and an emission wavelength of 510 nm. From the ratio
of measured ¯uorescence at the two excitation wavelengths, the
intracellular free calcium was calculated as previously described (Roe et
al, 1990).
NF-kB nuclear translocation by immuno¯uorescence
analysis Indirect immuno¯uorescence analyses for NF-kB localization
were performed as previously described (Ayoub et al, 2000; Dikov et al,
2001). Human keratinocytes were seeded at a concentration of 104±105
cells per well into chamber slides (154526, Nalgen Nunc International)
and allowed to grow to about 70% con¯uence. Cells then were either
treated with 50 ng per ml LPS or pretreated for 1 h with 1 mg per ml
anti-CD14 monoclonal antibody (MY4; Coulter), anti-TLR4
monoclonal antibody (HTA125; Bioscience), or anti-HLA class I
monoclonal antibody (HLA-A, HLA-B, HLA-C; Beckman Coulter)
before LPS treatment in speci®c experiments. Cells were then washed
twice with PBS, and ®xed in PBS containing 3.7% paraformaldehyde for
20 min at room temperature. Cells were washed again with PBS and
permeabilized by incubation with PBS containing 0.2% Triton X100 and
10% FBS for 20 min at room temperature. Cells were incubated for 1 h
at room temperature with rabbit antihuman NF-kB p65 antibody (Rel
A; Rockland, Gilbertsville, PA) diluted 1:500. Cells were washed three
times in PBS±FBS (10%), followed by a 1 h incubation with FITC-
conjugated af®nity-puri®ed goat antirabbit IgG (H + L; Jackson
ImmunoResearch Laboratories) diluted 1:300 at room temperature in the
dark. After washing cells three times in PBS, a drop of mounting reagent
containing 1 ml of Gelvatol (Airvol 203 Polyvinyl Alcohol; Airproducts
and Chemicals, Allentown, PA) and 100 mg 1,4-diazabicyclo
[2.2.2]octane (DABCO 2522; Sigma) was added, and the cells were
observed and photographed with a ¯uorescence microscope (Leica
Camera, Northvale, NJ).
Determination of cytokine and chemokine secretion by cultured
human keratinocytes by enzyme-linked immunosorbent assay
(ELISA) To quantify cytokine and chemokine secretion, cultured
human keratinocytes were plated in tissue culture ¯asks and after
Figure 3. Human keratinocytes express cell surface CD14 and TLR4. Surface expression of CD14 and TLR4 on human keratinocytes was
assessed by ¯ow cytometry. B lymphoblastoid JY-1 cells, which express no CD14 or TLR4, were used as a negative control and THP-1 human
monocytic cell line was used as a positive control for these studies (a, c). CD14 and TLR4 expression on the surface of human keratinocytes are shown
in each shaded histogram using CD14- and TLR4-speci®c monoclonal antibodies (b, d). Cells treated with an isotype-matched irrelevant antibody
served as an additional control in each panel (open histogram). The data shown are representative of studies conducted in triplicate.
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reaching con¯uence either were left untreated or were preincubated with
1 mg per ml anti-CD14 monoclonal antibody (V1153; Biomeda) or anti-
TLR4 monoclonal antibody (HTA125; Bioscience) for 2 h followed by
the addition of 100 ng per ml LPS. To determine the speci®city of these
antibody studies, control experiments were performed in which cells
were preincubated with an antibody directed against a monomorphic
determinant of human major histocompatibility complex (MHC) class I
HLA molecules (HLA-A, HLA-B, HLA-C; 1 mg per ml) followed by
exposure to LPS (100 ng per ml). After 12 h, the culture supernatants
were harvested and tested by ELISA (R&D Systems, Minneapolis, MN),
as previously described (Kennedy et al, 1997), to measure secreted IL-8.
In other studies (IL-1a and IL-1b), supernatants and cellular lysates were
also measured by ELISA. We show a representative experiment out of at
least three experiments in Figs 7, 8, 9. In the case of quantitative RT-
PCR and ELISA, we used at least three wells per sample in each
experimental condition on the plate to clarify the result.
Statistical analysis Results are expressed as mean 6 SD. For statistical
analysis, ANOVA with probabilities was performed for both the overall
signi®cance (p) and the pairwise comparison, indicated by asterisks. p
< 0.05 was considered to be signi®cant.
RESULTS
Human keratinocytes express CD14 and TLR4 mRNA To
determine whether CD14 and TLR4 mRNA are constitutively
expressed in cultured human keratinocytes, we performed northern
blot analysis using a [32P]-labeled speci®c cDNA probe for the gene
transcript for each receptor. The northern blot studies indicated
that human keratinocytes express both CD14 (1.3 kb) and TLR4
(2.4 kb) mRNA (Fig 1a, b). The relative levels of mRNA
expression in response to LPS were then analyzed by quantitative
RT-PCR and normalized to human 18S rRNA mRNA expression
for each experimental condition. The results of these studies
indicate that keratinocyte CD14 and TLR4 mRNA expression was
increased after the addition of 100 ng per ml LPS to cultured cells
(Fig 1c, d).
When the kinetics of this response were examined, CD14
mRNA expression was found to increase 3±24 h after the addition
Figure 4. Cultured human keratinocytes express immunoreactive
CD14 and TLR4. Immunostaining was carried out with keratinocyte
CD14 and TLR4 speci®c monoclonal antibodies (a, c). Human corneal
epithelial cells that served as positive controls for these studies were
similarly treated with antihuman CD14 and TLR4 monoclonal
antibodies (e, g). In negative control studies human keratinocytes (b, d )
and human corneal epithelial cells ( f, h) were treated with only a
secondary biotin-conjugated antimouse IgG. The data are representative
of independent experiments conducted in triplicate. Scale bar: 0.1 mm.
Figure 5. LPS induces increased intracellular Ca2+ in human
keratinocytes by a CD14- and TLR4-dependent mechanism.
Human keratinocytes were grown on glass coverslip culture dishes to
approximately 50%±70% con¯uence and ¯uorescent calcium probe fura-
2/AM was incorporated at 2 mM. (a) Human keratinocytes were treated
with 0.1% human serum alone. The cells were then treated with either
100 ng per ml LPS (b) with or without pretreatment with 1 mg per ml
of anti-CD14 (c), anti-TLR4 (d ), or anti-HLA MHC class I (e)
monoclonal antibodies for 20 min. In separate experiments, cells were
treated with 100 ng per ml LPS and 300 ng per ml polymyxin B,
simultaneously ( f ). Intracellular free calcium concentration was
determined by measuring the ratio of ¯uorescence at excitation
wavelengths of 340 and 380 nm. The peaks in this ®gure represent the
simultaneous intracellular calcium response of different cells to LPS.
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of LPS (Fig 2a), whereas TLR4 mRNA expression was increased
at 3 h and peaked 6±12 h after the addition of LPS (Fig 2b). These
results therefore demonstrate that human keratinocytes express
both CD14 and TLR4 mRNA that can be augmented by exposure
to LPS.
Human keratinocytes express cell surface CD14 and
TLR4 We next examined the cell surface expression of CD14
and TLR4 in human keratinocytes. Our results indicated that
CD14 and TLR4 cell surface expression can be detected on human
keratinocytes as determined by ¯ow cytometry (Fig 3b, d). THP-1
cells and JY-1 cells served as positive and negative controls,
respectively, in these studies (Fig 3a, c). Thus human keratinocytes
not only expressed CD14 and TLR4 mRNA but also expressed cell
surface CD14 and TLR4.
Cultured human keratinocytes are immunopositive for
CD14 and TLR4 We next determined whether CD14 and
TLR4 could be detected in cultured human keratinocytes. Our
studies indicated that cultured human keratinocytes were
immunoreactive for CD14 and TLR4 (Fig 4a, c, respectively)
like human corneal epithelial cells (Fig 4e, g, respectively) that we
previously reported to express CD14 and TLR4 and therefore
served as positive control cells for the keratinocyte studies (Song et
al, 2001). In contrast, little staining was found in human
keratinocytes (Fig 4b, d) and human corneal epithelial cells
(Fig 4f, h) treated with isotype-matched biotin-conjugated
antimouse IgG antibodies. Thus, immunopositive staining of
CD14 and TLR4 was detected in cultured human keratinocytes.
LPS induces CD14- and TLR4-dependent intracellular Ca2+
responses in human keratinocytes Keratinocytes represent a
critical initial barrier to cutaneous infections. In this study we tested
the functional competence of human keratinocyte CD14 and
TLR4 to respond to gram-negative bacterial derived LPS. Previous
studies by our laboratory indicated that LPS induced a rapid
increase in intracellular Ca2+ levels in human corneal epithelial cells
by a CD14- and TLR4-dependent mechanism (Song et al, 2001).
In this study, the addition of LPS to cultured human keratinocytes
likewise resulted in a rapid intracellular Ca2+ response (Fig 5b),
whereas the addition of human serum alone (0.1%) did not affect
intracellular Ca2+ mobilization (Fig 5a). The peaks in this ®gure
represent the simultaneous response of different cells to LPS. When
keratinocytes were preincubated with either anti-CD14 or anti-
TLR4 monoclonal antibodies (1 mg per ml) for 20 min before the
addition of LPS, the intracellular Ca2+ response was abrogated
(Fig 5c, d). In contrast, when keratinocytes were preincubated with
an irrelevant antibody directed against a monomorphic determinant
of MHC class I HLA, no inhibition of keratinocyte intracellular
Ca2+ ¯uctuation was observed after the addition of LPS (Fig 5e).
When keratinocytes were treated with LPS plus polymyxin B
(300 ng per ml) to con®rm that this response was due to LPS (not
to contaminants), no intracellular calcium ¯uctuation was detected
(Fig 5f). Therefore, these results demonstrate that LPS can trigger a
rapid induction of keratinocyte intracellular Ca2+ by a CD14- and
TLR4-dependent mechanism indicating the functionality of these
receptors.
LPS induces NF-kB nuclear translocation by a CD14- and
TLR4-dependent mechanism in human keratino-
cytes CD14 and TLR4 activation results in NF-kB activation
and nuclear translocation in leukocytes (Guha and Mackman,
2001). The role of these receptors in keratinocyte NF-kB responses
Figure 6. LPS induces NF-kB nuclear
translocation in human keratinocytes by a
CD14- and TLR4-dependent mechanism.
Indirect immuno¯uorescence analyses for cellular
NF-kB localization were performed using
chamber slide cultured human keratinocytes. NF-
kB immunolocalization was determined in 100 ng
per ml LPS-treated (a) and LPS-untreated (b)
keratinocytes. NF-kB translocation was also
measured in cells pretreated with anti-CD14 (c),
anti-TLR4 (d ), or anti-HLA class I (e)
monoclonal antibodies 1 h before LPS treatment.
As a negative control, keratinocytes were
incubated only with the FITC-conjugated
af®nity-puri®ed goat antirabbit IgG (H + L) ( f ),
and as a positive control, cells were treated with
50 ng per ml PMA (g). Scale bars: 50 mm.
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is unknown, however. NF-kB is a key transcriptional regulator of
multiple genes that participate in immune and in¯ammatory
responses (Baldwin, 1996; Ghosh et al, 1998; Karin and Delhase,
2000). In unstimulated cells, NF-kB is detected in the cytoplasm in
association with IkB. In response to cell stimulation by various
agents including proin¯ammatory cytokines and bacterial derived
products, IkB kinases are rapidly activated and phosphorylate IkB.
Phosphorylated IkB is then recognized by a speci®c ubiquitin ligase
complex and undergoes polyubiquitination, which targets these
proteins for degradation by the 26S proteasome. Once NF-kB is
separated from IkB, it translocates to the nucleus to activate gene
transcription of a variety of proin¯ammatory genes.
To test the role of keratinocyte CD14 and TLR4 in mediating
NF-kB responses to LPS, we analyzed NF-kB nuclear translocation
Figure 7. LPS induces keratinocyte IL-8 expression by a CD14- and TLR4-dependent mechanism. LPS induction of keratinocyte IL-8
mRNA expression and IL-8 secretion was examined by quantitative RT-PCR and ELISA. IL-8 mRNA expression was examined 6 h after the
addition of 100 ng per ml LPS to human keratinocytes with or without pretreatment with anti-CD14 or anti-TLR4 monoclonal antibodies (a). The
relative intensity of IL-8 mRNA expression was normalized with 18S rRNA mRNA for each experimental condition. The effect of LPS on secreted
keratinocyte IL-8 was measured in 12 h cell culture supernatants. In selected experiments LPS-induced IL-8 secretion was determined after pretreating
cells with anti-CD14, anti-TLR4, or human MHC class I HLA monoclonal antibodies (b, c). The effect of CD14, TLR4, and HLA MHC class I
antibodies on PMA-induced IL-8 secretion was also determined (c). The data shown are representative of triplicate experiments. All values are
expressed as mean 6 SD. Statistically signi®cant differences in IL-8 mRNA expression and secreted IL-8 in each experimental condition were
determined by ANOVA (*p < 0.001).
Figure 8. LPS induces keratinocyte IL-1a expression by a CD14- and TLR4-dependent mechanism. LPS induction of keratinocyte IL-1a
mRNA expression and IL-1a secretion was examined by quantitative RT-PCR and ELISA. IL-1a mRNA expression was examined 6 h after the
addition of 100 ng per ml LPS in human keratinocytes with or without pretreatment with anti-CD14 or anti-TLR4 monoclonal antibodies (a). The
relative intensity of IL-1a mRNA expression was normalized with 18S rRNA mRNA for each experimental condition. The effect of LPS on secreted
keratinocyte IL-1a was measured in 12 h cell culture supernatants. In selected experiments LPS-induced IL-1a secretion was determined after
pretreating cells with anti-CD14, anti-TLR4, or human MHC class I HLA monoclonal antibodies (b, c). The effect of CD14, TLR4, and HLA MHC
class I antibodies on PMA-induced IL-1a secretion was also determined (c). The data shown are representative of triplicate experiments. All values are
expressed as mean 6 SD. Statistically signi®cant differences in IL-1a mRNA expression and secreted IL-1a in each experimental condition were
determined by ANOVA (*p < 0.001).
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by immuno¯uorescent staining. As indicated in Fig 6, PBS-treated
keratinocytes demonstrated primarily cytoplasmic NF-kB staining
(Fig 6a), whereas the addition of 100 ng per ml LPS to the cells
induced a rapid NF-kB nuclear translocation (Fig 6b). To
determine the role of CD14 and TLR4 in the induction of NF-
kB nuclear translocation in response to LPS, human keratinocytes
were pretreated with anti-CD14 or anti-TLR4 monoclonal
blocking antibodies 1 h before LPS treatment. Pretreatment with
the anti-CD14 or anti-TLR4 monoclonal antibodies abrogated the
LPS-induced NF-kB nuclear translocation (Fig 6c, d). In contrast,
when keratinocytes were preincubated with an irrelevant anti-HLA
class I monoclonal antibody, no inhibition of NF-kB nuclear
translocation was observed after the addition of LPS (Fig 6e).
Likewise little cellular immuno¯uorescence could be detected
when the secondary antibody alone was added to the cells (Fig 6f).
PMA-treated cells, which served as a positive control for these
studies, also demonstrated NF-kB nuclear translocation as expected
(Fig 6g). These results indicate that LPS is capable of inducing the
NF-kB nuclear translocation in human keratinocytes by a CD14-
and TLR4-dependent mechanism.
LPS induces production of cytokines and chemokines in
human keratinocytes To examine the biologic role of the
keratinocyte CD14 and TLR4 in the initiation of innate
in¯ammatory responses to LPS, we measured the effect of LPS
on the production of selected proin¯ammatory chemokines and
cytokines by quantitative RT-PCR and ELISA. As IL-8 is a
principal chemotactic factor for neutrophils and is likely to
participate in all cutaneous infections, we examined the role of
CD14 and TLR4 in LPS-induced keratinocyte IL-8 production.
Human keratinocytes expressed increased IL-8 mRNA 6 h after
exposure to LPS (Fig 7a) and secreted increased amounts of IL-8
12 h after the addition of LPS (Fig 7b). To determine whether the
induction of human keratinocyte IL-8 by LPS was primarily
mediated by binding to CD14 or TLR4, human keratinocytes were
preincubated with blocking anti-CD14 or anti-TLR4 monoclonal
antibodies 2 h before the addition of LPS. Pretreatment with the
anti-CD14 or anti-TLR4 antibodies abrogated the induction of
keratinocyte IL-8 mRNA expression and IL-8 secretion in
response to LPS (Fig 7a, b, respectively). In contrast, when the
cells were preincubated with an irrelevant antibody directed against
a monomorphic determinant of MHC class I HLA, no effect on
LPS-induced IL-8 secretion was noted in human keratinocytes
(Fig 7b).
The role of CD14 and TLR4 in the induction of LPS-induced
keratinocyte IL-1 production was then examined as this proin-
¯ammatory cytokine is a key participant in cutaneous in¯ammatory
responses to a wide variety of noxious agents including bacteria. In
addition to IL-8, human keratinocytes also demonstrated increased
IL-1a and IL-1b mRNA 6 h after the addition of LPS (Figs 8a,
9a, respectively), and increased secretion of IL-1a and IL-1b 12 h
after the addition of LPS (Figs 8b, 9b, respectively). Preincubation
of the cells with anti-CD14 or anti-TLR4 monoclonal antibodies
2 h before the addition of LPS abrogated the increased IL-1a
(Fig 8a, b) and IL-1b (Fig 9a, b) production in response to LPS.
Again no effect was noted on LPS-induced keratinocyte IL-1a and
IL-1b production after the addition of anti-HLA MHC class I
antibodies (Figs 8b, 9b, respectively). To further determine the
speci®city of these responses, the effect of the anti-CD14 and anti-
TLR4 monoclonal antibodies on PMA-induced keratinocyte IL-8,
IL-1a, and IL-1b production was examined. These antibodies had
no effect on PMA-induced IL-8, IL-1a, and IL-1b production
(Figs 7c, 8c, 9c). These data demonstrate that LPS is capable of
directly activating human keratinocytes to express proin¯ammatory
cytokines and chemokines in a CD14- and TLR4-dependent
fashion.
Therefore, these studies demonstrate for the ®rst time that
normal human keratinocytes express functional CD14 and TLR4
LPS receptors. The activation of keratinocyte CD14 and TLR4
may play an important role in the initiation of bacterial derived
innate immune responses in the skin.
DISCUSSION
Gram-negative bacteria contain complex phospholipid-polysac-
charide macromolecules such as endotoxins and LPS, as an integral
Figure 9. LPS induces keratinocyte IL-1b expression by a CD14- and TLR4-dependent mechanism. LPS induction of keratinocyte IL-1b
mRNA expression and IL-1b secretion was examined by quantitative RT-PCR and ELISA. IL-1b mRNA expression was examined 6 h after the
addition of 100 ng per ml LPS in human keratinocytes with or without pretreatment with anti-CD14 or anti-TLR4 monoclonal antibodies (a). The
relative intensity of IL-1b mRNA expression was normalized with 18S rRNA mRNA for each experimental condition. The effect of LPS on secreted
keratinocyte IL-1b was measured in 12 h cell culture supernatants. In selected experiments LPS-induced IL-1b secretion was determined after
pretreating cells with anti-CD14, anti-TLR4, or human MHC class I HLA monoclonal antibodies (b, c). The effect of CD14, TLR4, and HLA MHC
class I antibodies on PMA-induced IL-1b secretion was also determined (c). The data shown are representative of triplicate experiments. All values are
expressed as mean 6 SD. Statistically signi®cant differences in IL-1b mRNA expression and secreted IL-1b in each experimental condition were
determined by ANOVA (*p < 0.001).
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part of the bacterial cell envelope. Although the systemic biologic
effects of LPS are numerous and well known, i.e., shock, fever, and
leukopenia, etc., the precise role of LPS in the pathogenesis of
various cutaneous diseases needs further study. There is substantial
evidence that LPS elicits its biologic effects by the engagement and
activation of speci®c cellular receptors. Although a number of
candidate proteins have been proposed to be components of the
LPS receptor complex (Lee et al, 1992; Tobias et al, 1993; Ingalls
and Golenbock, 1995; Schletter et al, 1995; El-Samalouti et al,
1997; Lien et al, 2000; Schroder et al, 2000), CD14 appears to
represent the principal binding element of the LPS receptor
complex. In previous investigations, CD14 expression was studied
primarily in myeloid-derived cells such as monocytes and
macrophages (Lee et al, 1992; Tobias et al, 1993; Ingalls and
Golenbock, 1995; Schletter et al, 1995; El-Samalouti et al, 1997;
Lien et al, 2000; Schroder et al, 2000). CD14 expression in these
leukocytes correlated with cellular responsiveness to LPS and
included the activation of downstream cellular signaling pathways
and cytokine production (Wright et al, 1990; 1991; Pugin et al,
1998). It has been proposed that nonleukocytes primarily respond
to LPS after it is combined with LPS-binding protein and soluble
CD14 (Goldblum et al, 1994; Hailman et al, 1994; Schumann et al,
1994; Tobias and Ulevitch, 1994; Tobias et al, 1995). We have
recently reported that human corneal cells express functional CD14
on their cell surface. The presence of cell membrane CD14 on
nonleukocytes suggests an important role for this molecule on cell
populations that serve in barrier locations that encounter invading
microorganisms. In this study, we demonstrate that human
keratinocytes are capable of expressing functional CD14 and that
LPS is capable of activating keratinocytes by a CD14-dependent
mechanism.
Because CD14 is a glycosylphosphatidylinositol-anchored
protein molecule that lacks an intracytoplasmic signaling domain,
other intracellular molecules are required for cellular responses to
LPS. Recent studies support this hypothesis by demonstrating that
LPS may bind not only to CD14 but also to TLR proteins either
independently or in conjunction with a CD14 complex (Yang et al,
1998). It was also reported that LPS binding to TLR4 alone,
however, is not as effective in generating a functional cellular
response as binding to the CD14±TLR4 complex (Means et al,
1999; Beutler, 2000b; Lien et al, 2000; Sugawara et al, 2000). TLR4
participates in CD14-dependent LPS responses (Jiang et al, 2000;
Schroder et al, 2000; Guha and Mackman, 2001; Lien et al, 2001; da
Silva Correia et al, 2001), and appears to be the predominant cell
surface signaling molecule for cellular LPS responses (Hoshino et al,
1999; Akashi et al, 2000a; Jiang et al, 2000). As multiple types of
TLR have been described on mammalian cells, it has been
proposed that the innate immune system may use different
combinations of TLRs to recognize different groups of microbial
pathogens. For example, TLR2 is activated by gram-positive
bacterial derived products such as lipoproteins or peptidoglycan in
macrophages (Schwandner et al, 1999) and Chinese hamster ovary
cell lines transfected with CD14 (Yoshimura et al, 1999), whereas
TLR9 responds to bacterial derived CpG oligonucleotides (Hemmi
et al, 2000). In addition to TLR4, we have also recently detected
functional TLR2 receptor in human keratinocytes (data not
shown).
The studies in this report demonstrate for the ®rst time that
human keratinocytes constitutively express the functional CD14±
TLR4 receptor complex. Although the precise mechanism by
which these receptors mediate cellular LPS responses requires
further investigation, we have demonstrated that LPS binding to
the human keratinocyte CD14±TLR4 complex initiates a rapid
intracellular Ca2+ response, NF-kB nuclear translocation, and the
production of proin¯ammatory cytokines and chemokines such as
IL-1a, IL-1b, and IL-8, which can initiate an ef®cient host
response to gram-negative skin infections. Although the relative
fold increase in the secretion of these cytokines is not to the same
degree as observed in cultured leukocytes, we believe that this is
due primarily to the high constitutive production of growth factors
and proin¯ammatory cytokines in cultured subcon¯uent keratino-
cytes. In contrast to the in vivo situation, these cultured cells have an
activated hyperproliferative wound healing type of phenotype. This
is further demonstrated by the modest 2-fold (over background)
increase in cytokine secretion even with the PMA-positive control
experiment. The functionality of keratinocyte CD14±TLR4 is also
supported by the increase in intracellular calcium response and NF-
kB activation in response to LPS.
The epidermis is one of the ®rst lines of defense against invading
microbial agents from external environments. As the epidermis is in
direct contact with environmental microorganisms, it is not
surprising that keratinocytes are endowed with the capacity to
initiate innate immune responses. Keratinocytes are signi®cantly
different from monocytes/macrophages in regard to function and
biologic response to various stimuli. Our data demonstrate that
these cells actively participate in cutaneous innate immunity by the
activation of speci®c microbial pattern recognition receptors, and
thus offer an opportunity to further understand the innate
immunologic responses in this barrier tissue. The activation of
keratinocyte CD14 and TLR4 may have both bene®cial and
detrimental in¯ammatory effects on the skin depending on the
effectiveness and duration of the host in¯ammatory response. There
is a fragile balance between generating a successful in¯ammatory
response to eliminate the offending microorganism and an excessive
in¯ammatory response that may result in chronic in¯ammatory and
infectious cutaneous diseases. Understanding the molecular patho-
genesis of LPS interactions with keratinocytes and the in¯ammatory
consequences of keratinocyte CD14±TLR4 complex activation
may permit the development of novel treatment strategies for
certain in¯ammatory and infectious diseases in the skin.
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